Bumper Offer - Urjas oil Just @ Rs. 1
Levenue 500 Tablet is a prescription drug, available for use as Tablet. Epilepsy are some of its major therapeutic uses. Secondary and off-label uses of Levenue 500 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Levenue 500 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Levenue 500 Tablet also has some side effects, the most common being Fatigue, Headache, Drowsiness. Besides the aforementioned side effects, there are other adverse effects of Levenue 500 Tablet as well, which are listed below. These side effects of Levenue 500 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Levenue 500 Tablet's effect is Moderate during pregnancy and Mild for lactating mothers. In addition, Levenue 500 Tablet's effects on the liver, heart and kidney are discussed below in the Levenue 500 Tablet related warnings section.
Some other conditions that can be affected by Levenue 500 Tablet are listed in the contraindications section below.
Besides this, Levenue 500 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Levenue 500 Tablet is considered not safe while driving, and is not addictive.
Levenue 500 Tablet is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Levenue 500 Tablet is used -
Moderate
Mild
Common
Is the use of Levenue 500 Tablet safe for pregnant women?
Levenue can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Levenue right away. Take your doctor's advice before taking it again.
Is the use of Levenue 500 Tablet safe during breastfeeding?
Side effects of Levenue for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Levenue 500 Tablet on the Kidneys?
Levenue rarely harms the kidneys.
What is the effect of Levenue 500 Tablet on the Liver?
Levenue is rarely harmful for the liver.
What is the effect of Levenue 500 Tablet on the Heart?
Levenue is completely safe for the heart.
Levenue 500 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Levenue 500 Tablet unless your doctor advises you to do so -
Is this Levenue 500 Tablet habit forming or addictive?
Levenue 500 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Levenue 500 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Levenue 500 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, in many cases, taking Levenue 500 Tablet can help with mental disorders.
Interaction between Food and Levenue 500 Tablet
Taking Levenue 500 Tablet with food does not harm your health.
Interaction between Alcohol and Levenue 500 Tablet
Taking alcohol with Levenue 500 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
